Get started Log in

HIK — Hikma Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Market Cap
£3.54bn
Enterprise Value
£4.54bn
Revenue
$3.16bn

REG - Hikma Pharmaceutical - Director/PDMR Shareholding
08/05/2025 16:45Announcement
REG - Hikma Pharmaceutical - S&P upgrades Hikma to ‘BBB’
08/05/2025 11:00Announcement
REG - Hikma Pharmaceutical - Settlement agreement for Xyrem® US lawsuits
08/05/2025 08:30Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
30/04/2025 13:30Announcement
REG - Hikma Pharmaceutical - Result of AGM
24/04/2025 16:00Announcement
REG - Hikma Pharmaceutical - Trading Statement
24/04/2025 07:02Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
10/04/2025 14:45Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
08/04/2025 14:00Announcement
REG - Hikma Pharmaceutical - Block listing Interim Review
01/04/2025 09:45Announcement
REG - Hikma Pharmaceutical - Annual Financial Report and Notice of AGM
19/03/2025 10:15Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
04/03/2025 11:30Announcement
REG - Hikma Pharmaceutical - Final Results
26/02/2025 07:15Announcement
REG - Hikma Pharmaceutical - Notice of Results
10/02/2025 08:15Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
23/12/2024 10:00Announcement
REG - Hikma Pharmaceutical - Outcome of Audit Tender Process
07/11/2024 15:45Announcement
REG - Hikma Pharmaceutical - Trading Statement
07/11/2024 07:00Announcement
REG - Hikma Pharmaceutical - 2024 Annual General Meeting Update Statement
24/10/2024 07:00Announcement
REG - Hikma Pharmaceutical - Block listing Interim Review
01/10/2024 09:45Announcement
REG - Hikma Pharmaceutical - Director/PDMR Shareholding
24/09/2024 10:15Announcement
REG - Hikma Pharmaceutical - Hikma completes Xellia acquisition
10/09/2024 07:00Announcement